ArticleEClinicalMedicine2026
The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.
Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Indirect protection from the typhoid conjugate vaccine (TCV) has been negligible, possibly due to vaccination being restricted to children, which may have limited the overall vaccine coverage needed to sufficiently interrupt transmission dynamics across endemic populations. In this study herd protection was evaluated in households and schools with different TCV coverages by conducting secondary analyses of a double-blind cluster-randomised trial on TCV in Bangladesh. Methods: TyVAC Bangladesh was a cluster-randomised trial conducted in Dhaka, Bangladesh between April 2018 and March 2020 (ISRCTN11643110 at www.isrctn.com). For this study, 150 geographical clusters were randomly assigned to receive TCV or Japanese encephalitis (JE) vaccine. Children aged 9 months to <16 years were vaccinated. Household-level herd protection was estimated by indirect vaccine effectiveness (iVE), comparing typhoid incidence among residents of all ages who did not receive the assigned study vaccine in TCV clusters with those in JE clusters using mixed-effects Poisson regression. The iVE was calculated as (1 - adjusted incidence rate ratio [aIRR]) × 100%. Household-level coverage was stratified by the number of vaccinated children (0, 1, ≥2) and the presence of eligible children. School-level herd protection was evaluated among students attending 35 primary and secondary schools who did not receive TCV by comparing typhoid incidence in high-coverage (>median) versus low-coverage schools (≤median), where school-level coverage was measured by the proportion of TCV-vaccinated students. The aIRR was estimated by mixed-effects Poisson regression. Findings: Household-level analysis included 129,601 unvaccinated residents from 40,435 households in the TCV arm and 129,973 unvaccinated residents from 40,577 households in the JE arm (median household size: 4.0 [IQR: 3.0, 5.0]). During 24-month follow-up between April 2018 and March 2020, the overall aIRR comparing all unvaccinated residents in TCV versus JE clusters was 0.91 [95% CI: 0.43, 1.91]. Stratified by household vaccine coverage, aIRR was 0.81 [95% CI: 0.15, 4.52] in households without eligible children and 0.97 [0.31, 3.04] in households with ≥ 1 eligible children but none vaccinated, and iVE was 25% [95% CI: -234, 83] and -26% [-766, 82] in households with ≥ 1 eligible children and 1, or ≥ 2 vaccinated children, respectively, with no significant interaction between number of vaccinees and arm (p = 0.85). School-level analysis (9209 children, 8%-55% TCV coverage) showed typhoid incidence of 349 [95% CI: 219, 528] and 329 [180, 552] per 100,000 person-years among non-TCV vaccinated students in low- and high-coverage schools, respectively (aIRR: 0.96 [95% CI: 0.28, 3.37]). Interpretation: Our study did not find significant herd protection across vaccine coverage levels in households and schools, although estimates were imprecise with wide confidence intervals. Funding: Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.